Related Experiment Video
Updated: Mar 29, 2026

09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
9.5K
Deaths at high altitude: Reducing the risk. A preliminary field study
1Unaffiliated (retired), UK jmacraeturner@btinternet.com.
Scottish Medical Journal
|November 27, 2015
Summary
This study found that altitude sickness symptoms and blood pressure changes during Himalayan treks are unpredictable above 4500 meters. Further research is needed on blood pressure at critical altitudes.
Area of Science:
- Altitude medicine
- Cardiovascular physiology
Background:
- Limited clinical studies on altitude sickness and blood pressure in adventure travelers.
- Need for data to advise General Practitioners (GPs) on pre-trek medical advice.
Purpose of the Study:
- To investigate altitude sickness symptoms and systemic blood pressure changes in relation to altitude.
- To provide data for GPs advising patients undertaking adventure holidays at altitude.
Main Methods:
- 17 trekkers gradually ascended Mera Peak in the Himalayas.
- Daily measurements of heart rate, blood pressure, oxygen saturation, peak expiratory flow, and core temperature.
- Hourly altitude checks and 24-hour ambulatory blood pressure monitoring for two individuals.
Main Results:
- No altitude sickness symptoms below 4000m; unpredictable symptoms arose above 4500m.
- Significant fall in oxygen saturation (O2sat) between 3500-4000m.
- No altitude effect on blood pressure below 3500m; marked, asymptomatic rise above 5000m.
Conclusions:
- A critical altitude may exist requiring increased vigilance.
- Further research on blood pressure at extreme altitudes is warranted.